Wei Danting, Somaratne Jithendra B, Lee Mildred, Kerr Andrew
Department of Cardiology, Counties Manukau District Health Board, Auckland, New Zealand.
Greenlane Cardiovascular Service, Auckland District Health Board, New Zealand.
N Z Med J. 2022 Oct 7;135(1563):70-81. doi: 10.26635/6965.5735.
Coronary angiography in patients with previous coronary artery bypass grafts (CABG) is technically more difficult with increased procedure time, radiation exposure and in-hospital complications. In a contemporary national registry of acute coronary syndrome (ACS) patients undergoing an invasive strategy, we compared the management and outcomes of patients with and without prior CABG.
The All New Zealand ACS Quality Improvement (ANZACS-QI) registry was used to identify patients admitted to New Zealand public hospitals with an ACS who underwent invasive coronary angiography (2014-2018). Outcomes were ascertained by anonymised linkage to national datasets.
Of 26,869 patients, 1,791 (6.7%) had prior CABG and 25,078 (93.3%) had no prior CABG. Prior CABG patients were older (mean age 71 years vs 65 years), more comorbid and less likely to be revascularised than those without CABG (49.8% vs 73.0%). Compared to patients without CABG, at a mean follow-up of 2.1 years, patients with prior CABG had higher all-cause mortality (HR 2.03 (1.80-2.29)), and were more likely to have recurrent myocardial infarction (HR 2.70 (2.40-3.04)), rehospitalisation with congestive cardiac failure (HR 2.36 (2.10-2.66)) and stroke (HR 1.82 (1.41-2.34)).
In contemporary real-world practice, despite half of the patients with ACS and prior CABG receiving PCI, the outcomes remain poor compared with those without prior CABG.
对于曾接受冠状动脉旁路移植术(CABG)的患者,冠状动脉造影在技术上难度更大,手术时间延长,辐射暴露增加,且院内并发症增多。在一项当代全国性急性冠状动脉综合征(ACS)患者侵入性治疗策略登记研究中,我们比较了有和没有既往CABG患者的治疗及预后情况。
使用全新西兰ACS质量改进(ANZACS-QI)登记研究来确定入住新西兰公立医院且接受侵入性冠状动脉造影的ACS患者(2014 - 2018年)。通过与国家数据集进行匿名关联来确定预后情况。
在26,869例患者中,1,791例(6.7%)有既往CABG史,25,078例(93.3%)无既往CABG史。与无CABG史的患者相比,有既往CABG史的患者年龄更大(平均年龄71岁对65岁),合并症更多,且血运重建的可能性更低(49.8%对73.0%)。与无CABG史的患者相比,在平均2.1年的随访中,有既往CABG史的患者全因死亡率更高(风险比[HR] 2.03[1.80 - 2.29]),更易发生再发性心肌梗死(HR 2.70[2.40 - 3.04])、因充血性心力衰竭再次住院(HR 2.3,6[2.10 - 2.66])和中风(HR 1.82[1.41 - 2.34])。
在当代实际临床实践中,尽管一半的ACS且有既往CABG史的患者接受了经皮冠状动脉介入治疗(PCI),但其预后与无既往CABG史的患者相比仍然较差。